Skip to main content

Advertisement

SpringerLink
Log in

Diet, obesity and cancer

  • Invited Commentary
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Introduction and aims

Obesity and the rising incidence of certain cancers are the manifest expressions of problems with diet and lifestyle. A number of complex and closely inter-related factors mediate the association between environment and cancer development. This review seeks to summarise the current evidence pertaining to dietary factors and cancer incidence and progression.

Methods

Relevant literature was identified by search of the Pubmed database using the terms: diet, cancer, carcinogenesis, tumourigenesis. References from relevant articles were searched. Selection of articles was based on peer review, journal and relevance. Where possible, meta-analyses of randomised controlled trials (RCTs) or large RCTs were cited preferentially.

Results

Variations in cancer trends between geographic regions and in migration studies point to the key role of environmental differences in cancer incidence. Mechanisms of tumorigenesis, including inflammation, angiogenesis, may be influenced by specific dietary constituents including glucosinolates, organosulphur compounds, genistein, curcumin, catechins, resveratrol and lycopene.

Conclusion

Despite epidemiological evidence suggesting a link between dietary factors and cancer development, confounding factors such as obesity, physical activity and the sheer variety of bioactive compounds in a normal diet pose a great challenge to the study of mechanisms linking diet and cancer. A greater understanding of the interplay between dietary constituents and cancer development should un-cover new targets for the prevention and treatment of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444:875–880

    Article  PubMed  Google Scholar 

  2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638

    Article  PubMed  Google Scholar 

  3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578

    Article  PubMed  Google Scholar 

  4. Morgan KMH, Watson D, Perry I et al (2008) SLAN 2007: survey of lifestyle, attitudes and nutrition in Ireland. Department of Health and Children, Dublin

    Google Scholar 

  5. Fund WCR (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective, 2nd edn. American Institute for Cancer Research, Washington

    Google Scholar 

  6. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894(i–xii):1–253

  7. Surh Y-J (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768–780

    Article  PubMed  CAS  Google Scholar 

  8. Folkman J, Hochberg M (1973) Self-regulation of growth in three dimensions. J Exp Med 138:745–753

    Article  PubMed  CAS  Google Scholar 

  9. Kerbel R, Folkman J (2002) Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727–739

    Article  PubMed  CAS  Google Scholar 

  10. Folkman J, Kalluri R (2004) Cancer without disease. Nature 427:787

    Article  PubMed  CAS  Google Scholar 

  11. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257

    Article  PubMed  CAS  Google Scholar 

  12. Cao Y, Cao R, Brakenhielm E (2002) Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem 13:380–390

    Article  PubMed  CAS  Google Scholar 

  13. Singh RP, Agarwal R (2003) Tumor angiogenesis: a potential target in cancer control by phytochemicals. Curr Cancer Drug Targets 3:205–217

    Article  PubMed  CAS  Google Scholar 

  14. Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8:98–101

    PubMed  CAS  Google Scholar 

  15. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  PubMed  CAS  Google Scholar 

  16. Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645

  17. Cowey S, Hardy RW (2006) The metabolic syndrome: a high-risk state for cancer? Am J Pathol 169:1505–1522

    Article  PubMed  CAS  Google Scholar 

  18. Barnes PJ, Karin M (1997) Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066–1071

    Article  PubMed  CAS  Google Scholar 

  19. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54:131–152

    Article  PubMed  CAS  Google Scholar 

  20. Hatcher H, Planalp R, Cho J, Torti F, Torti S (2008) Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631–1652

    Article  PubMed  CAS  Google Scholar 

  21. Azuine MA, Kayal JJ, Bhide SV (1992) Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity. J Cancer Res Clin Oncol 118:447–452

    Article  PubMed  CAS  Google Scholar 

  22. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer, base no. 5, version 2.0. IARC Press, Lyon

  23. López-Lázaro M (2008) Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol Nutr Food Res 52:S103–S127

    PubMed  Google Scholar 

  24. Shishodia S, Singh T, Chaturvedi MM (2007) Modulation of transcription factors by curcumin. In: The molecular targets and therapeutic uses of curcumin in health and disease. Adv Exp Med Biol 595:127–148

    Google Scholar 

  25. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “curecumin”: from kitchen to clinic. Biochem Pharmacol 75:787–809

    Article  PubMed  CAS  Google Scholar 

  26. Cheng AL, Hsu CH, Lin JK et al (2001) Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900

    PubMed  CAS  Google Scholar 

  27. Dhillon N, Aggarwal BB, Newman RA et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499

    Article  PubMed  CAS  Google Scholar 

  28. McKay DL, Blumberg JB (2002) The role of tea in human health: an update. J Am Coll Nutr 21:1–13

    PubMed  CAS  Google Scholar 

  29. Liao S (2001) The medicinal action of androgens and green tea epigallocatechin gallate. Hong Kong Med J 7:369–374

    PubMed  CAS  Google Scholar 

  30. Cabrera C, Artacho R, Gimenez R (2006) Beneficial effects of green tea—a review. J Am Coll Nutr 25:79–99

    PubMed  CAS  Google Scholar 

  31. Gary DS, Hasan M (1995) Polyphenols as cancer chemopreventive agents. J Cell Biochem 59:169–180

    Article  Google Scholar 

  32. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240

    Article  PubMed  CAS  Google Scholar 

  33. McLarty J, Bigelow RL, Smith M, Elmajian D, Ankem M, Cardelli JA (2009) Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila PA) 2:673–682

    Google Scholar 

  34. Shimizu M, Fukutomi Y, Ninomiya M et al (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prevent 17:3020–3025

    Article  CAS  Google Scholar 

  35. Clarke JD, Dashwood RH, Ho E (2008) Multi-targeted prevention of cancer by sulforaphane. Cancer Lett 269:291–304

    Article  PubMed  CAS  Google Scholar 

  36. Kjaerheim K, Gaard M, Andersen A (1998) The role of alcohol, tobacco, and dietary factors in upper aerogastric tract cancers: a prospective study of 10,900 Norwegian men. Cancer Causes Control 9:99–108

    Article  PubMed  CAS  Google Scholar 

  37. Shukla Y, Kalra N (2007) Cancer chemoprevention with garlic and its constituents. Cancer Lett 247:167–181

    Article  PubMed  CAS  Google Scholar 

  38. Graham DY, Anderson SY, Lang T (1999) Garlic or jalapeno peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol 94:1200–1202

    PubMed  CAS  Google Scholar 

  39. Iimuro M, Shibata H, Kawamori T et al (2002) Suppressive effects of garlic extract on Helicobacter pylori-induced gastritis in Mongolian gerbils. Cancer Lett 187:61–68

    Article  PubMed  CAS  Google Scholar 

  40. Hu J, Nyren O, Wolk A et al (1994) Risk factors for oesophageal cancer in northeast China. Int J Cancer 57:38–46

    Article  PubMed  CAS  Google Scholar 

  41. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 54:2390–2397

    PubMed  CAS  Google Scholar 

  42. Steinmetz KA, Kushi LH, Bostick RM, Folsom AR, Potter JD (1994) Vegetables, fruit, and colon cancer in the Iowa Women’s Health Study. Am J Epidemiol 139:1–15

    PubMed  CAS  Google Scholar 

  43. Hsing AW, Chokkalingam AP, Gao YT et al (2002) Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst 94:1648–1651

    PubMed  CAS  Google Scholar 

  44. Banerjee S, Li Y, Wang Z, Sarkar FH (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226–242

    Article  PubMed  CAS  Google Scholar 

  45. Yanagihara K, Ito A, Toge T, Numoto M (1993) Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res 53:5815–5821

    PubMed  CAS  Google Scholar 

  46. Mukhopadhyay S, Ballard BR, Mukherjee S, Kabir SM, Das SK (2006) Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats. Mol Cell Biochem 290:169–176

    Article  PubMed  CAS  Google Scholar 

  47. Kobayashi T, Nakata T, Kuzumaki T (2002) Effect of flavonoids on cell cycle progression in prostate cancer cells. Cancer Lett 176:17–23

    Article  PubMed  CAS  Google Scholar 

  48. Gossner G, Choi M, Tan L et al (2007) Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 105:23–30

    Article  PubMed  CAS  Google Scholar 

  49. Farina HG, Pomies M, Alonso DF, Gomez DE (2006) Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep 16:885–891

    PubMed  CAS  Google Scholar 

  50. Messina MJ, Persky V, Setchell KD, Barnes S (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:113–131

    Article  PubMed  CAS  Google Scholar 

  51. Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, Nakaizumi A (1999) Attenuation by genistein of sodium-chloride-enhanced gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int J Cancer 80:396–399

    Article  PubMed  CAS  Google Scholar 

  52. Williner MR, Pirovani ME, Güemes DR (2003) Ellagic acid content in strawberries. J Sci Food Agric 83:842–845

    Article  CAS  Google Scholar 

  53. Festa F, Aglitti T, Duranti G, Ricordy R, Perticone P, Cozzi R (2001) Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the Comet assay. Anticancer Res 21:3903–3908

    PubMed  CAS  Google Scholar 

  54. Wedge DE, Meepagala KM, Magee JB, Smith SH, Huang G, Larcom LL (2001) Short communication: anticarcinogenic activity of strawberry, blueberry, and raspberry extracts to breast and cervical cancer cells. J Med Food 4:49–51

    Article  PubMed  Google Scholar 

  55. Edderkaoui M, Odinokova I, Ohno I et al (2008) Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14:3672–3680

    Article  PubMed  CAS  Google Scholar 

  56. Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G (2005) Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. Eur Urol 47:449–455

    Article  PubMed  CAS  Google Scholar 

  57. Janick J (2005) Origins of fruits, fruit growing, and fruit breeding. Plant Breed Rev 25:255–320

    Google Scholar 

  58. Loza-Tavera H (1999) Monoterpenes in essential oils. Biosynthesis and properties. Adv Exp Med Biol 464:49–62

    PubMed  CAS  Google Scholar 

  59. Bardon S, Picard K, Martel P (1998) Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutr Cancer 32:1–7

    Article  PubMed  CAS  Google Scholar 

  60. Wagner KH, Elmadfa I (2003) Biological relevance of terpenoids Overview focusing on mono-, di- and tetraterpenes. Ann Nutr Metab 47:95–106

    Article  PubMed  CAS  Google Scholar 

  61. Elegbede JA, Elson CE, Qureshi A, Tanner MA, Gould MN (1984) Inhibition of DMBA‐induced mammary cancer by the monoterpene d‐limonene. Carcinogenesis 5:661–664

    Google Scholar 

  62. Haag JD, Gould MN (1994) Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene. Cancer Chemo Pharmacol 34:477–483

    Google Scholar 

  63. Kris‐Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113:71–88

    Google Scholar 

  64. Rabi T, Bishayee A (2009) Terpenoids and breast cancer chemoprevention. Breast Cancer Res Treat 115:223–239

    Article  PubMed  CAS  Google Scholar 

  65. Tapiero H, Townsend DM, Tew KD (2004) The role of carotenoids in the prevention of human pathologies. Biomed Pharmacother 58:100–110

    Article  PubMed  CAS  Google Scholar 

  66. Dorjgochoo T, Gao YT, Chow WH et al (2009) Plasma carotenoids, tocopherols, retinol and breast cancer risk: results from the Shanghai Women Health Study (SWHS). Breast Cancer Res Treat 117:381–389

    Article  PubMed  CAS  Google Scholar 

  67. Van Patten CL, de Boer JG, Tomlinson Guns ES (2008) Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol 180:2314–2321; discussion 721–722

    Google Scholar 

  68. Haseen F, Cantwell MM, O’Sullivan JM, Murray LJ (2009) Is there a benefit from lycopene supplementation in men with prostate cancer. A systematic review. Pros Cancer Pros Dis 12:325–332

    Article  CAS  Google Scholar 

  69. Renaud S, de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339:1523–1526

    Article  PubMed  CAS  Google Scholar 

  70. Liu BL, Zhang X, Zhang W, Zhen HN (2007) New enlightenment of French Paradox: resveratrol’s potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther 6:1833–1836

    Article  PubMed  CAS  Google Scholar 

  71. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506

    Article  PubMed  CAS  Google Scholar 

  72. Doll R, Hill AB (2004) The mortality of doctors in relation to their smoking habits: a preliminary report. 1954 BMJ 2004;328:1529–1533; discussion 33

    Google Scholar 

  73. Lynch LA, O’Connell JM, Kwasnik AK, Cawood TJ, O’Farrelly C, O’Shea DB (2009) Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) 17:601–605

    Article  CAS  Google Scholar 

  74. O’Shea D, Cawood TJ, O’Farrelly C, Lynch L (2010) Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke. PLoS One 5:e8660

    Article  PubMed  Google Scholar 

  75. Howard JM, Pidgeon GP, Reynolds JV (2010) Leptin and gastro-intestinal malignancies. Obes Rev 11(12):863–874. doi:10.1111/j.1467-789X.2010.00718.x

    Google Scholar 

  76. Doyle SL, Lysaght J, Reynolds JV (2009) Obesity and post-operative complications in patients undergoing non-bariatric surgery. Obes Rev 11(12):875–886

    Google Scholar 

  77. Healy LA, Ryan AM, Rowley S et al (2009) Obesity increases the risk of postmenopausal breast cancer and is associated with more advanced stage at presentation but no impact on survival. Breast J 25(11):1293–1299

    Google Scholar 

  78. Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV (2010) Obesity and gastrointestinal cancer. Br J Surg 97:628–642

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Trinity Centre for Health Sciences, Trinity College Dublin/St. James’ Hospital, Dublin 8, Ireland

    J. V. Reynolds, C. L. Donohoe & S. L. Doyle

Authors
  1. J. V. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. L. Donohoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. L. Doyle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. V. Reynolds.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reynolds, J.V., Donohoe, C.L. & Doyle, S.L. Diet, obesity and cancer. Ir J Med Sci 180, 521–527 (2011). https://doi.org/10.1007/s11845-010-0653-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-010-0653-5

Keywords

Search

Navigation